This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT05980000
Brief Title: Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma (Rambro2)

First Submitted : July 30, 2023
First Submitted that Met QC Criteria : July 30, 2023
First Posted : August 7, 2023

Last Update Submitted that Met QC Criteria : January 27, 2024
Last Update Posted : January 30, 2024